Protection from secondary human immunodeficiency virus type 1 infection in chimpanzees suggests the importance of antigenic boosting and a possible role for cytotoxic T cells

Journal of Infectious Diseases

Volumn 184, Issue 2, 2001, Pages 136-143

  Balla Jhagjhoorsingh, S S ^a   Mooij, P ^a   Ten Haaft, P J F ^a   Bogers, W M J M ^a   Teeuwsen, V J P ^a   Koopman, G ^a   Heeney, J L ^a  

^a BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; VIRUS RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHIMPANZEE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HELPER CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOREGULATION; LYMPHOCYTE COUNT; NONHUMAN; PRIORITY JOURNAL; VIRUS ISOLATION; VIRUS RECOMBINANT;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AIDS VACCINES; ANIMALS; HIV INFECTIONS; PAN TROGLODYTES; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0035879821     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/322019     Document Type: Article

References (41)

1. Genetic diversity of HIV-1: The moving target
2. Horizontal and vertical transmission of human immunodeficiency virus type I dual infections caused by viruses of subtypes B and C
3. Recombination in HIV-1: Update and implications
4. Dual infection with human immunodeficiency virus type I of distinct envelope subtypes in humans
5. A molecular epidemiologic survey of HIV in Uganda
6. Distribution of HIV-1 subtypes seen in an AIDS clinic in Sāo Paulo City, Brazil
7. HIV type 1 in Thailand, 1994-1995: Persistence of two subtypes with low genetic diversity
8. Extensive diversification of human immunodeficiency virus type 1 subtype B strains during dual infection of a chimpanzee that progressed to AIDS
9. Development of AIDS in a chimpanzee infected with human immunodeficiency virus type 1
10. Identification of a window period for susceptibility to dual infection with two distinct human immunodeficiency virus type 2 isolates in a Macaca nemestrina (pig-tailed macaque) model
11. Protective immunity induced by live attenuated simian immunodeficiency virus
12. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene
13. Highly attenuated vaccine strains of simian immunodeficiency virus protect against vaginal challenge: Inverse relationship of degree of protection with level of attenuation
14. Immune correlates of protection from HIV and AIDS: More answers but yet more questions
15. Developments in preclinical AIDS vaccine efficacy models
16. How important is the "quality" of the cytotoxic T lymphocyte (CTL) response in protection against HIV infection?
17. A phase I trial in HIV negative healthy volunteers evaluating the effect of potent adjuvants on immunogenicity of a recombinant gp120W61D derived from dual tropic R5X4 HIV-1ACH320
18. The resistance of HIV-infected chimpanzees to progression to AIDS correlates with absence of HIV-related T-cell dysfunction
19. A clinically relevant HIV-1 subunit vaccine protects rhesus macaques from in vivo passaged simian-human immunodeficiency virus infection
20. HIV-1 envelope - Elicited neutralizing antibody titres correlate with protection and virus load in chimpanzees
21. Virus load in chimpanzees infected with human immunodeficiency virus type 1: Effect of pre-exposure vaccination
22. Protection from HIV-1 envelope bearing chimeric simian immunodeficiency virus (SHIV) in rhesus macaques infected with attenuated SIV: Consequences of challenge
23. Enumeration of lymphokine-secreting cells as a quantitative measure for cellular immune responses in rhesus macaques
24. Major histocompatibility complex class I-associated vaccine protection from simian immunodeficiency virus-infected peripheral blood cells
25. Conserved CTL epitopes shared between HIV-infected human long-term survivors and chimpanzees
26. Characteristics of primary infection of a European human immunodeficiency virus type I clade B isolate in chimpanzees
27. Control of viremia in simian immunodeficiency virus infection by CD8- lymphocytes
28. Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques
29. Sexual behaviour and sexually transmitted infection among African and Caribbean men in London
30. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS
31. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women
32. Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure
33. Cytotoxic T lymphocyte responses in the peripheral blood of children born to human immunodeficiency virus-1-infected mothers
34. HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant
35. Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya
36. Absence of specific mucosal antibody responses in HIV-exposed uninfected sex workers from the Gambia
37. - lymphocyte responses in the cervix of HIV-1-resistant prostitutes in Nairobi
38. + cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection
39. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type I syndrome
40. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA
41. Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques